Dr Surulivel Rajan M

Professor & Head

12.09.2005

Department of Pharmacy Practice

CURRENT ACADEMIC ROLE & RESPONSIBILITIES

    Dr. M Surulivelrajan?completed post-doctoral?fellowship at University of North Texas System College of Pharmacy, USA. He?is working in the area of Pharmacometrics to develop models for drug pharmacokinetics and pharmacodynamics to develop medication compliance model.?He has following roles and responsibilities:

    • Staff Coordinator for fifth Year Pharm.D program
    • Approved PhD guide
    • Guide for M.Pharm dissertation work and Pharm.D project
    • Coordinator of Department 必威体育betway888 Committee (DRC)
    • Coordinator of Centre for?Pharmacometrics

    ?

ACADEMIC QUALIFICATIONS

Degree Specialisation Institute Year of passing
Post-doctoral Fellowship Pharmacometrics University of North Texas System College of Pharmacy 2018
PhD (Doctor of Philosophy) Population Pharmacokinetics 必威体育betway888 College of Pharmaceutical Sciences, 必威体育betway888 Academy of Higher Education 2011
Post Graduate Diploma in Clinical 必威体育betway888 Clinical 必威体育betway888 Institute of Clinical 必威体育betway888, New Delhi 2004

Experience

Institution / Organisation Designation Role Tenure
Department of Pharmacy Practice, MCOPS 必威体育betway888 Professor 2022-onwards
Department of Pharmacy Practice, MCOPS 必威体育betway888 Associate Professor
Department of Pharmacy Practice, MCOPS 必威体育betway888 Assistant Professor – Selection Grade 2012
Department of Pharmacy Practice, MCOPS 必威体育betway888 Assistant Professor 2011
Department of Pharmacy Practice, MCOPS 必威体育betway888 Senior Lecturer 2007
Department of Pharmacy Practice, MCOPS 必威体育betway888 Lecturer 2005
PSG College of Pharmacy, Coimbatore Lecturer Taught undergraduate students and providing clinical pharmacy services to the affiliated hospital. 2004-2005
Sri Ramachandra College of Pharmacy, Chennai Lecturer Taught undergraduate students and providing clinical pharmacy services to the affiliated hospital. 2001-2003

AREAS OF INTEREST, EXPERTISE AND RESEARCH

Area of Interest

Clinical Pharmacy

Area of Expertise

Population Pharmacokinetic Models

Area of 必威体育betway888

Pharmacometrics, Clinical Services of Pharmacists

Professional Affiliations & Contributions

  • Founder Member of KSPOR, 2010.
  • Founder Member of ACPI, 2007.
  • Life Member of IHPA, 2008.
    ?

Work Experience

Organisation Role Tenure
USV Limited, Mumbai Business Development Executive Worked in the assessment of product portfolio and involved in both the scientific and market assessment of the products to be launched

Population pharmacokinetics of lamotrigine in Indian epileptic patients

2013-01-01 Martin G Johnson Thiyagu Rajakannan Padma GM Rao Lokesh Bathala

European Journal of Clinical pharmacology, 2013, 69(1):43-52.

Cost of adverse reactions in a 必威体育betway888 Indian tertiary care teaching hospital

2012-01-01 Thiyagu Rajakannan Vasudeva Guddattu Asha Kamath Rajesh V

Journal of Clinical Pharmacology, 2012, 52:559-565.

Development and validation of an instrument to assess the perception of pharmacy students on medication review process

2012-01-01 Rao JR Sravanthi LK Rajat TS

Indian Journal of Pharmacy practice, 2012, 5(3):69-74.

Pattern of angiotensin - converting enzyme inhibitors induced adverse drug reactions in 必威体育betway888 Indian teaching hospital

2012-01-01 Uday Venkat Mateti Haritha Nekkanti Rajesh V Thiyagu Rajakannan

North American Journal of Medical Sciences. 2012, 4(4):185-9.

High performance liquid chromatographic fluorescence detection method for the quantification of rivastigmine in rat plasma and brain - Application to preclinical pharmacokinetic studies in rats

2011-01-01 Arumugam K Chamallamudi MR Mullangi R Ganesan S

Journal of Young Pharmacists. 2011, 3(4):315-321.

Potential drug interactions in patients admitted to cardiology wards of a 必威体育betway888 Indian teaching hospital

2011-01-01 Virendra K P Leelavathi D Acharya Thiyagu R Vasudeva G

Australasian Medical Journal AMJ 2011, 4, 1, 9-14.

Drug-drug interactions in hospitalized hospitalised cardiac patients

2011-01-01 Mateti UV Rajakannan T Nekkanti H Rajesh V

J Young Pharm, 2011, 3(4): 329-333.

A sensitive and selective HPLC method for estimation of lamotrigine in human plasma and saliva - application to plasma-saliva correlation in epileptic patients

2010-01-01 Karthik Arumugam Tarun jain Thiyagu R Krishnamurthy B

Arzeimittel Forschung, 2010, 60(10); 599-606.

Study of tissue and the plasma concentrations of cefotaxime to assess its suitability for prophylaxis in cholecystectomy

2010-01-01 Leelavathi D Acharya Suresh S Anand Rao Sohil Ahmed Khan

Journal of Clinical and Diagnostic research必威体育betway888, 2010, 4:2410-2415.

Development of indicators for identifying adverse drug events in an Indian tertiary care teaching hospital

Rajakannan Thiyagu Rajesh V Smitha Prabhu Sudha Vidyasagar

Drug, Health care Care and patient Patient safetySafety, 2010, 2:95-100 .

Video assisted patient education improves compliance with follow up and depression scores in Inflammatory Bowel Diseases.

Kamat N Rajan Mallayasamy S Sharma PSVN Kamath A Pai CG

Postgraduate Medicine, 2018;130(3):355-360.

Direct costs for nonsurgical management of Chronic Pancreatitis in a tertiary care teaching hospital.

Kamat N Pai G Mallayasamy SR Kamath A S R

Expert Review of Pharmacoeconomics and Outcomes 必威体育betway888, 2018;18(3):315-320.

Cost of Illness in Inflammatory Bowel Disease.

Kamat N Ganesh Pai C Surulivel Rajan M Kamath A.

Digestive Diseases and Science, 2017;62(9):2318-2326.

Assessment of cost of illness for diabetic patients in 必威体育betway888 Indian tertiary care hospital.

Acharya LD Rau NR Udupa N Rajan MS Vijayanarayana K

Journal of Pharmacy and Bioallied Sciences, 2016;8(4):314-320.

Full Publications list

Therapeutic drug monitoring of Lamotrigine in Plasma and Saliva

2007-01-01 Abhishek Pradhan

2007, PG This project involved the study of drug level monitoring of lamotrigine in plasma and saliva.

Development of dosage regimen for valproate using Population pharmacokinetic simulations

2012-01-01 Shivsagar

2012.This project involved the use of complex NONMEM software for the development of pharmacokinetic simulations.